Covenant Metabolic Specialists LLC
Industry / private company
Location:
Sarasota, FL,
United States (USA) (US)
ROR: https://ror.org/04q9zc034
A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis (2022)
Bowlus CL, Galambos MR, Aspinall RJ, Hirschfield GM, Jones DE, Dörffel Y, Gordon SC, et al.
Journal article